QDEL Quidel Corp
Price (delayed)
$40.46
Market cap
$2.72B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$27.89
Enterprise value
$5.3B
Quidel Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration has issued the first emergency
Highlights
QDEL's quick ratio is down by 30% YoY but it is up by 8% from the previous quarter
The equity has contracted by 36% YoY
Quidel's gross profit has decreased by 14% YoY
Key stats
What are the main financial stats of QDEL
Market
Valuations
Earnings
Shares outstanding
67.26M
Market cap
$2.72B
Enterprise value
$5.3B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.85
Price to sales (P/S)
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.88
Revenue
$2.82B
Gross profit
$1.34B
Operating income
-$1.82B
Net income
-$1.87B
EBIT
-$1.84B
EBITDA
-$1.38B
Free cash flow
-$93.8M
Per share
Balance sheet
Liquidity
EPS
-$27.89
EPS diluted
-$27.89
Free cash flow per share
-$1.39
Book value per share
$47.4
Revenue per share
$41.87
TBVPS
$48.06
Total assets
$6.8B
Total liabilities
$3.61B
Debt
$2.72B
Equity
$3.19B
Working capital
$385.3M
Debt to equity
0.85
Current ratio
1.38
Quick ratio
0.43
Net debt/EBITDA
-1.87
Margins
Efficiency
Dividend
EBITDA margin
-49%
Gross margin
47.6%
Net margin
-66.2%
Operating margin
-64.6%
Return on assets
-26%
Return on equity
-50.9%
Return on invested capital
-38.4%
Return on capital employed
-31.9%
Return on sales
-65.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QDEL stock price
How has the Quidel stock price performed over time
Intraday
-1.39%
1 week
-0.27%
1 month
-7.46%
1 year
-18.23%
YTD
-9.18%
QTD
-9.18%
Financial performance
How have Quidel's revenue and profit performed over time
Revenue
$2.82B
Gross profit
$1.34B
Operating income
-$1.82B
Net income
-$1.87B
Gross margin
47.6%
Net margin
-66.2%
Quidel's gross profit has decreased by 14% YoY
QDEL's revenue is down by 10% year-on-year
QDEL's gross margin is down by 5% YoY
Growth
What is Quidel's growth rate over time
Valuation
What is Quidel stock price valuation
P/E
N/A
P/B
0.85
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.88
The stock's price to book (P/B) is 75% less than its 5-year quarterly average of 3.4 and 6% less than its last 4 quarters average of 0.9
The equity has contracted by 36% YoY
QDEL's P/S is 71% below its 5-year quarterly average of 3.4 and 19% below its last 4 quarters average of 1.2
QDEL's revenue is down by 10% year-on-year
Efficiency
How efficient is Quidel business performance
Quidel's return on equity has decreased by 13% QoQ
QDEL's return on assets is down by 7% since the previous quarter
Dividends
What is QDEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QDEL.
Financial health
How did Quidel financials performed over time
QDEL's total assets is 88% greater than its total liabilities
QDEL's quick ratio is down by 30% YoY but it is up by 8% from the previous quarter
QDEL's total assets is down by 20% year-on-year
QDEL's debt is 15% less than its equity
The debt to equity has surged by 60% year-on-year
The equity has contracted by 36% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.